Kedudukan dalam Saham
#13455
Artrya Limited is a medical technology firm that harnesses artificial... Artrya Limited is a medical technology firm that harnesses artificial intelligence (AI) to pinpoint individuals at risk of developing coronary artery disease. The company's key offering is Salix, a cloud-based software application. Salix leverages Artrya's proprietary AI to automate the identification of coronary artery disease through the analysis of coronary computed tomography angiography (CCTA) scans. Founded in 2018, the company is headquartered in West Perth, Australia.
Perubahan (1 hari)
-10.74%
Perubahan (1 tahun)
114.71%
Perdagangan Artrya Limited (AYA)
Harga AYA dengan permodalan pasaran b
Modal pasaran bagi Artrya Limited(AYA)
Modal Pasaran: $487.33M
Sehingga August 2026, Artrya Limited mempunyai modal pasaran sebanyak $487.33M. Ini menjadikan Artrya Limited syarikat ke-13455th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Artrya Limited dari 2021 hingga 2026
AYA berbanding dengan 5 teratas yang paling popular stocks
| Harga AYA |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.325T
|
+1,092,641.11%
|
|
|
|
|
$4.609T
|
+945,678.39%
|
|
|
|
|
$4.062T
|
+833,349.21%
|
|
|
|
|
$3.797T
|
+779,043.37%
|
|
|
|
|
$2.810T
|
+576,485.85%
|
